Table 2.
Variable |
Control 1
(n = 24) |
Control 2
(n = 22) |
Intervention
(n = 20) |
Total
(n = 66) |
P value
One-Way ANOVA Test |
---|---|---|---|---|---|
Age (years) | 31.7 ± 5.1 | 30.6 ± 5 | 30.2 ± 5.4 | 30.9 ± 5.1 | 0.575 |
Duration of infertility (years) | 6.4 ± 3.2 | 4.4 ± 2.4 | 5.6 ± 2.8 | 5.5 ± 2.9 | 0.064 |
Number of oocytes retrieved | 11.7 ± 4.3 | 11.9 ± 5.4 | 11.1 ± 4.6 | 11.6 ± 4.7 | 0.833 |
MII | 7.0 ± 2.9 | 7.8 ± 3.5 | 6.9 ± 2.9 | 7.2 ± 3.1 | 0.593 |
MI | 2.2 ± 1.8 | 1.5 ± 1.5 | 1.5 ± 1.7 | 1.8 ± 1.7 | 0.231 |
GV | 2.1 ± 1.6 | 2.4 ± 2.3 | 2.5 ± 1.6 | 2.3 ± 1.8 | 0.736 |
Serum 17 β-estradiol*(Pg/ml) | 3666.7 ± 2475.2 | 3782.4 ± 2091.8 | 4380.2 ± 3270.0 | 3928.1 ± 2630.4 | 0.649 |
Serum LH (IU/L) | 5.06 ± 2.9 | 7.3 ±4.6 | 5.4 ± 2.4 | 5.9 ± 3.5 | 0.080 |
Serum FSH (IU/L) | 6.2 ± 2.4 | 6.9 ± 2.1 | 6.2 ± 1.8 | 6.4 ±2.1 | 0.466 |
Serum TSH (μIU/L) | 2.6 ± 2.0 | 1.9 ± 1.0 | 2.2 ± 1.0 | 2.3 ±1.4 | 0.385 |
Serum PRL (ng/ml) | 124.3 ± 173.7 | 226.2 ± 283.7 | 78.7 ± 141.5 | 145.5 ±215.9 | 0.075 |
Serum AMH (ng/ml) | 5.6 ± 5.7 | 3.8 ± 3.5 | 7.3 ±6.9 | 5.6 ±5.7 | 0.175 |
On the day of hCG administration; LH: luteinizing hormone; FSH: follicle-stimulating hormone; TSH: thyroid-stimulating hormone; PRL: prolactin; AMH: anti-mullerian hormone; MII: mature oocyte (Meiosis II); MI: immature oocyte (Meiosis I); GV: Germinal Vesicle.